A 45-year-old female, known case of type 2 diabetes mellitus for 16 years on insulin, achalasia cardia for 15 years on repeated endoscopic dilatations (last done 6 months back) was brought to the emergency room in an unconscious state. She had frothing from mouth; there were no signs of injury or sphincteric incontinence. Clinically, she was hemodynamically stable, had altered sensorium (Glasgow coma scale: E4M4V3), normal papillary response, no gaze deviation, focal neurological deficit or neck stiffness. Her random plasma glucose was 33 mg/dl, rest of biochemistry, hematology and neuroimaging was normal. She was managed as severe hypoglycemia with intravenous dextrose, insulin was stopped. She recovered completely though gradually in 48 h. After recovery, she gave a history of persistent dysphagia, abdominal pain, weight loss and regurgitation of food material; erratic glycemic control (glucose levels fluctuating between 50 mg/dl and 450 mg/dl; hemoglobin A1c (HbA1c) 10.8%) including severe hypoglycemia 15 days back prompting modification of insulin regimen from premix to multiple insulin injections, dose modification and change of insulin type to analogs (lispro and glargine). Barium swallow showed dilated sigmoid esophagus with a minimal leak of contrast into the stomach and delayed esophageal emptying time of 1 h \[[Figure 1](#F1){ref-type="fig"}\]. Upper gastrointestinal (GI) endoscopy showed dilated esophagus, impaired lower esophageal sphincter relaxation, poor peristalsis and residual food debris \[[Figure 2](#F2){ref-type="fig"}\]. She underwent laparoscopic Heller\'s myotomy, but continued to have dysphagia and glycemic excursions. Hence, her bolus insulin injection timing was shifted to 45-60 min postprandially. Her glycemic control improved (plasma glucose range: 150-250 mg/dl, HbA1c 8.3%) and she did not experience any major hypoglycemic episodes in the following 6 months of follow-up \[[Figure 3](#F3){ref-type="fig"}\].

![Barium swallow showing dilated sigmoid esophagus (megaesophagus) with a minimal leak of contrast into stomach](IJEM-17-338-g001){#F1}

![Upper gastrointestinal endoscopy showing dilated esophagus with narrow lower esophageal sphincteric opening](IJEM-17-338-g002){#F2}

![Glycemic variation pre-intervention (multiple values recorded over previous 2 months) and post-intervention (over 6 months of follow-up)](IJEM-17-338-g003){#F3}

Achalasia cardia occurs due to degeneration of inhibitory neurons of the myenteric plexus resulting in poor lower esophageal sphincter relaxation and loss of peristalsis.\[[@ref1]\] Primary form is thought to occur due to inflammatory, autoimmune or genetic neurodegeneration while secondary form is seen in Chaga\'s disease (*Trypanosoma cruzi*), diabetes mellitus and malignancies (pseudoachalasia). The diagnosis is made by barium swallow and manometry. Upper GI endoscopy is carried out to confirm the diagnosis and to rule out malignancy.\[[@ref2]\] Treatment involves repeated endoscopic pneumatic dilatations that are effective for a short period (6-12 months) while definitive treatment is Heller\'s myotomy that gives relief from dysphagia for a longer period (80% for 5 years).\[[@ref2]\] Other less effective therapeutic modalities include injection of botulinum toxin, nitrates and calcium channel blockers.\[[@ref3]\] Long standing achalasia may lead to megaesophagus further worsening outcome.\[[@ref3]\] Diabetes mellitus *per se* also can cause esophageal disorders namely reduced amplitude of esophageal contractions, reduced peristalsis, increased esophageal transit time and acid reflux due to the degeneration of autonomic nervous system.\[[@ref4]\] Tight glycemic control can prevent these complications that are irreversible in nature. Combination of both these disorders, reported rarely as case reports,\[[@ref5][@ref6]\] can be very troublesome both for patient and treating physician.

Our patient presented with severe hypoglycemia due to "meal -- insulin mismatch" caused by delayed glucose peak as a result of delayed emptying of esophageal contents and inappropriately early insulin peak as insulin was being given 30-45 min before meals. Associated autonomic neuropathy could also have contributed towards glycemic excursions. She was treated along standard lines for achalasia with suboptimal outcome due to its long duration while shifting of bolus insulin postprandially along with other interventions resulted in improved glycemic control and reduced fluctuations.

Long-term outcome of these patients is not very satisfying; however, with appropriate therapeutic strategies they can be allayed distressing and potentially fatal complications.
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